Author:
MUKHSINZODA N.A., ,UMAROVA S.G.,
Abstract
Objective: To study the experience of a comprehensive diagnosis of cervical intraepithelial neoplasia (CIN) based on the results of the first pilot visual screening in the Republic of Tajikistan. Methods: The first pilot visual screening in two large districts of the Republic of Tajikistan was carried out in 2016. A total of 68,391 women of the target groups took part in this study, of which 26,691 (39%) were from the Kushoniyon district and 41,700 (61%) from the B. Gafurov district. According to the algorithm of organized visual screening, extended colposcopy, cytological examination, and biopsy with histological examination were performed. Results: According to the results of the tests performed, in 164 cases (0.24%) CIN was diagnosed, while in 20 cases (0.03%) cervical cancer (CC) was detected (p<0.001). Mild low-grade squamous intraepithelial lesions (LSIL) lesions were detected in 99 cases (70 women from B. Gafurov district and 29 patients from Kushoniyon district), while severe high-grade squamous intraepithelial lesions (HSIL) were detected in 65 cases (59 women from B. Gafurov district and 6 women from Kushoniyon district). Patients with histologically confirmed precancerous pathology and cervical cancer were referred for outpatient and inpatient treatment. Conclusion: The strategy of organized visual screening 'detection-diagnosis-treatment', recommended by WHO for countries with limited resources, is optimal for implementation in the conditions of the Republic of Tajikistan at the national level. Keywords: Cervical intraepithelial neoplasia, visual screening, VIA/VILI visual method, colposcopy.
Publisher
Avicenna Tajik State Medical University
Subject
Psychiatry and Mental health
Reference13 articles.
1. 1. Virus papillomy cheloveka i rak sheyki matki [elektronnyy resurs]. VOZ. 2019: 4. URL: https://www.who.int/ru/news-room/fact-sheets/detail/human-papillomavirus-(hpv)-and-cervical-rak [Human papillomavirus and cervical cancer]. WHO. 2019: 4. URL: https://www.who.int/ru/news-room/fact-sheets/detail/ human-papillomavirus-(hpv)-and-cervical-cancer
2. 2. GLOBOCAN 2018, http://gco.iarc.fr/©International Agency for Research on Cancer. 2018: 12.
3. 3. Abdugaffarova NA. Sostoyanie zabolevaemosti rakom sheyki matki v Respublike Tadzhikistan [The state of the incidence of cervical cancer in the Republic of Tajikistan]. Opukholi zhenskoy reproduktivnoy sistemy. 2022;18(2):69-77.
4. 4. Mirzoev AS, Nazurdinov AB, Tursunov RA, Azizov ZA. Epidemiologicheskie aspekty vliyaniya vaktsiny protiv virusa papillomy cheloveka v profilaktike raka sheyki matki v global'nom masshtabe i rekomendatsii po eyo vnedreniyu v Tadzhikistane [Epidemiological aspects of the impact of the human papillomavirus vaccine in the prevention of cervical cancer on a global scale and recommendations for its implementation in Tajikistan]. Vestnik Smolenskoy gosudarstvennoy meditsinskoy akademii. 2019;18(3):139-47.
5. 5. Comprehensive cervical cancer control: A guide to essential practice - 2nd ed. World Health Organization. 2014.